天坛生物：8月20日召开董事会会议

Group 1 - The core viewpoint of the article highlights that Tiantan Biological Products (SH 600161) held its 24th meeting of the 9th Board of Directors on August 20, 2025, to review the special report on the use of raised funds for the first half of 2025 [1] - For the first half of 2025, the company's revenue composition shows that the biological products industry accounted for 99.68%, while other businesses contributed 0.32% [1] - As of the report's release, Tiantan Biological has a market capitalization of 40.7 billion yuan [1]